AstraZeneca plc with EPIC/TICKER (LON:AZN) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘OVERWEIGHT’ this morning by analysts at Barclays Capital. AstraZeneca plc are listed in the Health Care sector within UK Main Market. Barclays Capital have set their target price at 7600 GBX on its stock. This is indicating the analyst believes there is a potential upside of 11.1% from today’s opening price of 6841 GBX. Over the last 30 and 90 trading days the company share price has increased 476 points and increased 998 points respectively. The 52 week high for the stock is 6895 GBX while the 52 week low is 5312 GBX.
AstraZeneca plc has a 50 day moving average of 6,306.12 GBX and a 200 day moving average of 6,108.07. There are currently 1,311,783,132 shares in issue with the average daily volume traded being 2,065,014. Market capitalisation for LON:AZN is £89,345,549,120 GBP.
